Ortho-Preferred

Clodronate


- Discussion: 
- one of the first bisphosphonates used to treat patients with cancer-related hypercalcemia;
- it can be administered either as an intravenous infusion in a dose of 4-6 mg per km given over a period of two to five hours qd for 3-5 days or as single IV infusion given over 2-9 hr period




Original Text by Clifford R. Wheeless, III, MD.

Last updated by Data Trace Staff on Thursday, September 8, 2011 3:23 pm